Status:
COMPLETED
Effect of Lactoferrin Supplementation on Urinary Tract Infections in Infants.
Lead Sponsor:
Medical University of Lublin
Collaborating Sponsors:
Pharmabest Sp. z o.o.
Conditions:
Urinary Tract Infections in Children
Eligibility:
All Genders
7-12 years
Phase:
PHASE3
Brief Summary
The aim of the study was to evaluate the efficacy of orally administered bovine lactoferrin (bLF) on Urinary Tract Infections in neonates and infants. Fifty-five patients with urinary tract infection ...
Detailed Description
This study was a prospective randomized controlled trial at a single university medical center. Participants were neonates or infants with Urinary Tract Infection (UTI) admitted to the Neonatal and In...
Eligibility Criteria
Inclusion
- Neonates and infants with symptoms of Urinary Tract Infection.
- Active infection at enrollment, confirmed and documented in medical record.
- Children with Urinary Tract Infection treated according to current recommendations.
Exclusion
- Unconfirmed Urinary Tract Infection.
- Critical illness and/or hemodynamic instability.
- Allergy or sensitivity to lactoferrin or bovine derived proteins or bovine milk.
- Children whose parents/guardians decline to participate.
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2018
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT06109688
Start Date
July 1 2015
End Date
February 15 2018
Last Update
October 31 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.